Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: heparin agents attending: chief complaint: mental status changes secondary to acute hemmorrhagic cva. major surgical or invasive procedure: none history of present illness: 51 yo m s/p mechanical redo-avr for endocarditis in c/b take back for tamponade. he completed his antibiotic course at home but then was hospitalized on for picc line sepsis with serratia sensitive to cipro. he was started on cipro, the picc was dc'd and he was discharged. he was readmitted on with altered mental status and found to have an acute hemoorhage in the left parietal lobe iwht breakthrough hemorrhage in the left lateral ventricle and third ventricle with subfalcine shift up to 7mm. craneictomy was performed, he was stabilized and transferred to for further management of his id issues. past medical history: pmh thrombocytopenia, copd, hepc, endocarditis/diskitis, depression, anxiety, avr ' social history: + tobacco 20 pack years denies etoh unemployed family history: nc physical exam: nad, a&o x 3 rrr, no m/r/g lungs ctab abdomen benign extrem no edema skin msi well healed, left craniotomy c/d/i with staples. left ue & le strenth , right ue & le strength 3/4 pertinent results: 07:45am blood wbc-3.2* rbc-3.59* hgb-10.7* hct-32.2* mcv-90 mch-29.9 mchc-33.3 rdw-15.6* plt ct-93* 10:00am blood pt-24.7* ptt-37.2* inr(pt)-2.4* 07:45am blood glucose-94 urean-24* creat-0.7 na-135 k-5.2* cl-98 hco3-30 angap-12 05:25pm blood alt-20 ast-26 ld(ldh)-265* alkphos-90 amylase-94 totbili-0.6 radiology final report ct head w/o contrast 3:53 pm ct head w/o contrast reason: please assess ich medical condition: 51 year old man with s/p ich x 2 / now on anticoagulation reason for this examination: please assess ich contraindications for iv contrast: none. clinical history: 51-year-old male status post intracranial hemorrhage, now on anticoagulation. heterogeneous focus of high-attenuation is seen within the left frontoparietal with surrounding vasogenic edema, slightly improved compared to prior exam from . mixed density extra-axial collection persists along the left cerebral convexity subjacent to the craniotomy site. a new 4-mm focus of high- attenuation is seen within the right occipital lobe (series 2, image 14), likely representing a hemorrhage. compared to the prior exam, the degree of sulcal effacement in the left cerebral hemisphere and mass effect exerted upon the left lateral ventricle is unchanged. there is no hydrocephalus or shift of normally midline structures. the visualized sinuses and mastoid air cells remain normally aerated. impression: 1. evolving intraparenchymal hemorrhage within the left parietal lobe, with minimal improvement in the surrounding vasogenic edema since . , portable tte (complete) done at 12:21:04 pm final referring physician information , , status: inpatient dob: age (years): 51 m hgt (in): 71 bp (mm hg): 110/70 wgt (lb): 130 hr (bpm): 95 bsa (m2): 1.76 m2 indication: left ventricular function. endocarditis. icd-9 codes: v42.2, 424.1, 424.2, 424.0, 424.90 test information date/time: at 12:21 interpret md: , md test type: portable tte (complete) son: , rdcs doppler: full doppler and color doppler test location: / 6 contrast: none tech quality: adequate tape #: 2008w000-0:00 machine: vivid i-3 echocardiographic measurements results measurements normal range left atrium - long axis dimension: *4.4 cm <= 4.0 cm left atrium - four chamber length: *5.3 cm <= 5.2 cm right atrium - four chamber length: *5.1 cm <= 5.0 cm left ventricle - septal wall thickness: *1.4 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: *1.3 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 4.3 cm <= 5.6 cm left ventricle - systolic dimension: 3.0 cm left ventricle - fractional shortening: 0.30 >= 0.29 left ventricle - ejection fraction: >= 55% >= 55% left ventricle - lateral peak e': 0.10 m/s > 0.08 m/s left ventricle - septal peak e': *0.06 m/s > 0.08 m/s left ventricle - ratio e/e': 10 < 15 aorta - sinus level: 3.1 cm <= 3.6 cm aorta - ascending: 3.3 cm <= 3.4 cm aorta - arch: *3.2 cm <= 3.0 cm aortic valve - peak velocity: *3.3 m/sec <= 2.0 m/sec aortic valve - peak gradient: *44 mm hg < 20 mm hg aortic valve - mean gradient: 26 mm hg mitral valve - e wave: 0.8 m/sec mitral valve - a wave: 0.7 m/sec mitral valve - e/a ratio: 1.14 mitral valve - e wave deceleration time: *348 ms 140-250 ms tr gradient (+ ra = pasp): 13 to 19 mm hg <= 25 mm hg findings this study was compared to the prior study of . left atrium: mild la enlargement. right atrium/interatrial septum: mildly dilated ra. left ventricle: mild symmetric lvh with normal cavity size and global systolic function (lvef>55%). mild regional lv systolic dysfunction. no resting lvot gradient. right ventricle: normal rv chamber size and free wall motion. aorta: normal aortic diameter at the sinus level. normal ascending aorta diameter. mildly dilated aortic arch. no 2d or doppler evidence of distal arch coarctation. aortic valve: bileaflet aortic valve prosthesis (avr). increased avr gradient. small vegetation on aortic valve. trace ar. mitral valve: mildly thickened mitral valve leaflets. no mvp. mild mitral annular calcification. mild thickening of mitral valve chordae. trivial mr. lv inflow pattern c/w impaired relaxation. tricuspid valve: normal tricuspid valve leaflets with trivial tr. normal pa systolic pressure. pulmonic valve/pulmonary artery: thickened pulmonic valve leaflets. physiologic (normal) pr. conclusions the left atrium is mildly dilated. there is mild symmetric left ventricular hypertrophy with normal cavity size and global systolic function (lvef>55%). there is very mild regional left ventricular systolic dysfunction with septal hypokinsis. right ventricular chamber size and free wall motion are normal. the aortic arch is mildly dilated. a bileaflet aortic valve prosthesis is present. the transaortic gradient is higher than expected for this type of prosthesis. there is a small vegetation/?thrombus (0.5cm x 0.4cm) on the aortic valve (clip ). trace aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. there is no mitral valve prolapse. trivial mitral regurgitation is seen. the left ventricular inflow pattern suggests impaired relaxation. the estimated pulmonary artery systolic pressure is normal. the pulmonic valve leaflets are thickened. compared with the prior study (images reviewed) of , the small mass on the prosthetic aortic valve is new with increased transvalvular gradient. the left ventricular systolic function may be better. radiology preliminary report carot/cereb 11:16 am carot/cereb reason: was recurrent left parietal bleed caused by a mycotic aneury contrast: optiray medical condition: 51 year old man with history of endocarditis and avr who had a recurrent left parietal bleed. reason for this examination: was recurrent left parietal bleed caused by a mycotic aneurysm or avm? history: 51-year-old male patient with history of endocarditis and aortic valve replacement had recurrent left parietal bleed. evaluate for mycotic aneurysm or arteriovenous malformation. procedure performed: right common carotid arteriogram, right internal carotid arteriogram, left internal carotid arteriogram, left external carotid arteriogram and right vertebral artery arteriogram. 2. new 4-mm punctate focus of high-attenuation in the right occipital lobe, consistent with hemorrhage. the study and the report were reviewed by the staff radiologist. dr. dr. brief hospital course: he was admitted to cardiac surgery. he was started on vanco, cipro and gent. he was seen by neurosurgery and restarted on coumadin and heparin secondary to the risk of embolic stroke from his mechanical valve. tee showed no evidence of recurrent endocarditis. vanco and gentamycin were dc'd. mra showed no evidence of mycotic aneurysm. prostate u/s was negative as well, and his cipro was dc'd. repeat head ct on showed worsening intracranial hemorrhage, and he was transferred to the icu for closer monitoring. his anticoagulation was held and he received 4 units of ffp. angiography on which demonstrates no aneurysm, vascular malformation or arteriovenous fistula. he was transferred back to the floor. anticoagulation continued to be held. prior to restarting anticoagulation, repeat head ct on showed slight improvement in trapping of left temporal . otherwise minimal change compared to prior study. hit was found to be positive, argatroban and coumadin were started. a serotonin assay was sent.infectious diseases was consulted for recommendations if deemed necessary. he awaited therapeutic inr for discharge to home with vna. head ct showed an evolving intraparenchymal hemorrhage within the left parietal lobe, with minimal improvement in the surrounding vasogenic edema since .and new 4-mm punctate focus of high-attenuation in the right occipital lobe, consistent with hemorrhage. neurosurgery was reconsulted and a repeat head ct was performed prior to discharge which showed no short-term interval change compared to ct from at 15:57. neurosurgery recommended anticoagulation with coumadin.mr. was discharged to home with vna services on . medications on admission: naficillin 2gm q4h (staph), asa, lasix 40', kcl, methadone 15"', roxicodone 15 prn, rifampin discharge medications: 1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). disp:*30 tablet, chewable(s)* refills:*0* 2. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours) for 1 months. disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 3. hydrocodone-acetaminophen 5-500 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. disp:*40 tablet(s)* refills:*0* 4. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. methadone 10 mg tablet sig: one (1) tablet po three times a day. 7. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 8. sertraline 50 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 9. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*0* 10. outpatient work pt/inr mon-wed-fri with goal inr 2.5-3.0 for mechanical avr results to dr office # fax # . 11. coumadin 5 mg tablet sig: 1.5 tablets po once a day for 2 days: please take 7.5mg on mon and tues - have inr checked for further coumadin dosing . disp:*90 tablet(s)* refills:*0* discharge disposition: home with service facility: vna discharge diagnosis: ich heparin induced thrombocytopenia pmh chronic diastolic heart failure endocarditis bacteremia bentall w/ homograft ' hepatitis c chronic pain depression anxiety discharge condition: good discharge instructions: pt/inr mon-wed-fri with goal inr 2.5-3.0 for mechanical avr results to dr office # fax # . no lifting greater than 10 pounds for 10 weeks from date of surgery call for fevers greater 100.5 redness or drainage from wounds no driving until cleared by neurology shower daily, wash and pat incisions dry please call with any questions or concerns followup instructions: please call to schedule appointments dr in 2 weeks dr (neurology) 2 weeks dr in 3 weeks dr in 3 weeks pt/inr mon-wed-fri with goal inr 2.5-3.0 for mechanical avr results to dr office # fax # . procedure: diagnostic ultrasound of heart arteriography of cerebral arteries transfusion of other serum computerized axial tomography of head diagnoses: coronary atherosclerosis of native coronary artery tobacco use disorder congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified unspecified viral hepatitis c without hepatic coma aortocoronary bypass status intracerebral hemorrhage dysthymic disorder heart valve replaced by other means long-term (current) use of anticoagulants personal history of noncompliance with medical treatment, presenting hazards to health anticoagulants causing adverse effects in therapeutic use subdural hemorrhage chronic diastolic heart failure unemployment 

Answer: The patient is high likely exposed to